Dr Margulis on Key Considerations When Navigating Frontline Combination Regimens in RCC
September 26th 2023Vitaly Margulis, MD, discusses key disease characteristics and patient factors to consider when selecting between IO/IO vs IO/TKI treatment combinations for the management of patients with renal cell carcinoma.
Read More